Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nikolova, AleksandrovfiledCriticalNikolova
Priority to BG100777UpriorityCriticalpatent/BG330Y1/en
Publication of BG100777UpublicationCriticalpatent/BG100777U/en
Publication of BG330Y1publicationCriticalpatent/BG330Y1/en
The medicamentous form has combined cerebral protective,hepatoprotective and antiphlogistic effect. It is suitable forcontinous outpatient prophylaxy and for the treatment of vascularcerebral deficiency and age alterations of the cerebral function.It is in the form of a tablet, film-tablet or in a hard gelatinecapsule containing 2-oxopyrrolydon-1-acetamide (Pyrracetam),potassium orotate and vitamin E adsorbate 50% as active componenttogether with known auxiliary substances and carriers. Thepyrracetam content is 0.050-2.500 g, of the potassium orotate0.010-2.000 g and vitamin E adsorbate 50 - 0.002-0.240 g.\!
BG100777U1996-08-121996-08-12Solid batched medicamentous form of cobined antihypoxy preparation
BG330Y1
(en)
Meth. FOREVER. OF PHOSPHORORGANIC DERIVATIVES OF 2,4-DI-T-BUTYLPHENOL, 4,4'-DIHALOGEN MAGNESIUM COMPOUNDS OF BIFENYL AND USE. OF THE PHOSPHORORGANIC DERIVATIVES FOR STABILIZATION OF ARTIFICIALS, SPECIFICALLY IN POLYOLEFINE MASSES.
3,4-dioxo-1-cyclobuten-1-yl-substituted (indolyl-alkyl)-pyridine- and -pyrimidine derivatives and antimigraine composition containing them as active componens